Vanguard Health Care Fund (Ticker: VGHCX)
The investment objective of Vanguard Health Care fund is to provide long-term capital appreciation. The mutual fund invests majority of its assets (>80%) in the stocks of companies mainly engaged in the development, production, or distribution of products and services related to the health care industry. These companies may include pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities. It may invest in companies engaged in medical, diagnostic, biochemical, and other research and development activities. The fund may invest in domestic and foreign stocks.Fund Profile
- Fund Inception Date: May 22, 1984
- Ticker Symbol: VGHCX
- CUSIP: 921908307
- Beta (3yr): 0.52
- Category: Health
- Distribution/ Yield: 0.88%
- Capital Gains: 0%
- Expense Ratio: 0.37%
- Net Assets: $ 46.4 billion
- Number of Years Up: 22 years
- Number of Years Down: 5 years
- Annual Turnover Rate: 12.00%
- Fund Manager: Jean M. Hynes
Since its inception in May 1984, the fund advisor is Wellington Management Company, LLP. As part of Vanguard fund family, it has big total net assets of $23.25 billion. The dividend yield is 1.46%. VGHCX fund has no management fee. It is also a no-load fund therefore it doesn’t charge any front-end sales load fee or deferred sales load fee. The annual net expense ratio is 0.35%. It is 77% lower than the average expense ratio of funds with similar holdings. The average ratio in the category is 1.49%.
Best Health Sector Stock Mutual Funds 2012
Morningstar ranks this health mutual fund with 4-stars rating. This Vanguard fund has recorded 22 years of positive return and 5 years of negative return since its inception. It has YTD return of 14.40%. The 5-year annualized return is 5.44%. The worst performance year occurred in 2008 with -18.45%. The best was in 2000 with 60.56%. The performance of this fund based on the load adjusted returns is as follows:
- Year 2017: 11.95% (YTD)
- Year 2016: -8.99%
- Year 2015: 12.65%
- Year 2014: 28.52%
- Year 2013: 43.19%
- Year 2012: 15.11%
The month-end 10 largest holdings as of September 2012 are Merck & Co Inc, UnitedHealth Group Inc, Amgen Inc, Pfizer Inc, Roche Holding AG, Forest Laboratories Inc, Abbott Laboratories, McKesson Corp, Eli Lilly & Co and Astellas Pharma Inc. They equal to 40.2% of the total net assets. The top sector diversifications are Pharmaceuticals (51.40%), Managed Health Care (12.90%), Biotechnology (9.40%) & Health Care Equipment (9.40%).
According to the fund prospectus, the investment risks are industry concentration risk, stock market risk, manager risk, country risk, currency risk, etc.
Disclosure: No Position
Other fund review:
Note: This Vanguard Health Care Fund (VGHCX) is part of Kiplinger's 25 best mutual funds.
No comments:
Post a Comment